https://www.selleckchem.com/products/nu7026.html
The SAMe-TT R score helps identify patients with atrial fibrillation (AF) likely to have poor anticoagulation control during anticoagulation with vitamin K antagonists (VKA) and those with scores 2 might be better managed with a target-specific oral anticoagulant (NOAC). We hypothesized that in clinical practice, VKAs may be prescribed less frequently to patients with AF and SAMe-TT R scores 2 than to patients with lower scores. We analyzed the Phase III dataset of the Global Registry on Long-Term Oral Antithrombotic Treatment in
Like
Comment
Share
